Leadership


  • Image attribution tooltip
    E+ via Getty Images

    As pharma M&A ramps up, U.S. execs are bullish on more deals

    What top executives at Merck, Pfizer and more are saying about M&A as they move into the second half of the year.

    By Aug. 11, 2022
  • Miruna Sasu COTA
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: COTA’s Miruna Sasu

    Miruna Sasu is on a mission to use real world data to help wipe out cancer. She believes this audacious goal is within reach, and as president and CEO of COTA, she is inspiring her team to create a “path to care” for oncology patients.

    By Aug. 10, 2022
  • CEO pay
    Image attribution tooltip
    Stock via Getty Images

    Are Big Pharma CEOs earning their pay?

    While compensation packages at the top may not always reflect value, it’s not necessarily an industrywide problem.

    By Kelly Bilodeau • Aug. 8, 2022
  • A hand picks a blue figurine out of rows of similar wooden figurines.
    Image attribution tooltip
    Ivan Balvan via Getty Images

    Editas, Real Chemistry and Compass blaze new trails with pivotal C-suite hires

    How these latest executive personnel changes are impacting the industry. 

    By Aug. 3, 2022
  • Heather Schwoebel head shot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Alloy Therapeutics’ Heather Schwoebel

    The CBO and COO is leaning on her experience navigating the unknown to turn Alloy into an innovation multiplier.

    By Aug. 3, 2022
  • Artifical intelligence
    Image attribution tooltip
    Olemedia via Getty Images
    Q&A

    How a speech analysis tool could transform diagnosis and research for Alzheimer’s and beyond

    WinterLight’s machine learning platform assesses speech to more accurately identify neurodegenerative diseases.

    By Kim Ribbink • Aug. 1, 2022
  • A person points a pen at a computer with a green line graph. A blurred computer in the background shows other graphs.
    Image attribution tooltip
    iStock via Getty Images

    What’s next for Biogen? Here’s what executives are saying

    A trickling launch for Aduhelm and a middling earnings report give Biogen executives a lot to talk about. Is there hope?

    By July 27, 2022
  • Katie Williams head shot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Applied BioMath's Katie Williams

    The 2022 president of Women in Bio is equal parts math and gender parity evangelist. 

    By July 27, 2022
  • J&J CEO Joaquin Duato
    Image attribution tooltip
    Mike Coppola/Staff via Getty Images

    With big changes ahead for J&J and Novartis, here's what the companies' execs are talking about

    Both J&J and Novartis are making — or considering — big shifts in their fundamental company makeup.

    By July 21, 2022
  • A person holds a magnet pointed at multi-colored wooden figures of people sitting on dark wood-grain table.
    Image attribution tooltip
    iStock via Getty Images

    Making moves: Agios, BeiGene, Biocom California and more announce new key hires

    The latest executive personnel changes from around the industry.

    By July 18, 2022
  • Women checking smartphone while drinking coffee
    Image attribution tooltip

    DeanDrobot/Shutterstock.com

    Sponsored by Avant Healthcare

    Digital Opinion Leader deep-dive: the sharer

    Learn about Digital Opinion Leaders who curate tailored content experiences and provide value to their followers. 

    July 18, 2022
  • gene therapy
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    First 90 Days: Anjarium Biosciences' Stephen Yoo

    The incoming CEO aims to build on the buzz around the company’s leading-edge gene therapy tech.

    By Kim Ribbink • July 15, 2022
  • A black stethoscope rests diagonally on a rainbow flag background.
    Image attribution tooltip
    Sasirin Pamai via Getty Images
    Q&A

    Janssen extends LGBTQ mental health outreach beyond Pride Month

    The pharma giant’s ‘Depression looks like me’ campaign assembles a ‘one stop shop’ of resources to help combat high rates of severe depression in the LGBTQ community.

    By July 14, 2022
  • Son holding father's hand at the hospital
    Image attribution tooltip
    FG Trade via Getty Images
    Profile

    The power of the underdog: A rare disease nonprofit working to help patients win against the odds

    Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.

    By Alexandra Pecci • July 13, 2022
  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Kura Oncology's Kirsten Flowers

    How the chief commercial and corporate strategy officer is embracing a ‘full-cup’ philosophy to build a better leadership toolbox.

    By July 13, 2022
  • None
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    The CEO of Dr. Reddy's N. America is using 'controlled explosions' to keep the generics giant growing

    Marc Kikuchi weighs in on the company’s plans to pump up its pipeline and sales in the coming years.

    By July 7, 2022
  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: CinCor Pharma's Terry Coelho

    From M&Ms to biotech, the chief financial officer's sweet tooth for taking risks is paying off. 

    By July 6, 2022
  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Novartis' Marie-France Tschudin

    How the chief commercial officer and president of innovative medicines international plans to fuel growth and productivity at the company.

    By June 29, 2022
  • Katalin Kariko and Drew Weissman
    Image attribution tooltip
    Permission granted by University of Pennsylvania
    Q&A

    The scientist's struggle: Lessons from the journey of mRNA pioneers Katalin Karikó and Drew Weissman

    The two Penn Medicine researchers whose work brought the mRNA vaccines into COVID-19 fruition want to see the pharma world embrace early science.

    By June 29, 2022
  • A magnifying glass is held over a wooden block with a business person's silhouette etched on it.
    Image attribution tooltip
    iStock via Getty Images

    Making moves: Walgreens, Merck, eClinical Solutions and more announce key new hires

    The latest personnel changes from around the industry.

    By June 29, 2022
  • SaNOtize CEO Gilly Regev
    Image attribution tooltip
    Permission granted by SaNOtize/Gilly Regev
    Profile

    From vineyards to antivirals, Gilly Regev brings creative thinking to science

    The CEO of SaNOtize is tapping into outside-the-box innovation to develop a nitric oxide-delivery platform to treat and prevent COVID-19.

    By Alexandra Pecci • June 27, 2022
  • None
    Image attribution tooltip
    Stock via Getty Images

    4 tips for landing your next C-suite role in pharma

    Even execs get the blues — and when they’re ready for a fresh start, Leslie Loveless, CEO of Slone Partners, says these dos and don’ts could make or break their next job move.

    By June 23, 2022
  • None
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Kronos Bio's Barbara Kosacz

    Deal-maker, mentor and biotech industry mover and shaker, the COO and general counsel brings her 'smiling tiger' skills to her new role at the emerging company.

    By June 21, 2022
  • A person in a white doctors coat and stethoscope holds up a magnifying glass.
    Image attribution tooltip
    Valiantsin Suprunovich via Getty Images

    The public health sleuth

    In her decades-long career, Mary Pittman, CEO of the Public Health Institute, has seen — and helped solve — one public health mystery after another.

    By Alexandra Pecci • June 21, 2022
  • Chicago skyline
    Image attribution tooltip
    Michael Gibney/PharmaVoice

    #DIA2022: How the industry's top regulator views the future of healthcare

    In the evolution of healthcare, data is the linchpin to making drug development more efficient.

    By June 21, 2022